Entering text into the input field will update the search result below

Premarket analyst action - healthcare

  • Unity Biotechnology (NASDAQ:UBX) initiated with Overweight rating and $25 (92% upside) at Morgan Stanley. Initiated with Neutral rating and $17 price target at Goldman Sachs. Phase 1 study of OAK candidate UBX0101 to start this quarter. Shares up 3% premarket.
  • Inspire Medical Systems (NYSE:INSP) initiated with Outperform rating at Wells Fargo. Initiated with Buy rating and $42 (35% upside) price target at Stifel. Initiated with Neutral rating and $25 price target at Goldman. Initiated with Buy rating and $40 price target at Guggenheim. Initiated with Buy rating and $32 price target at Citigroup.
  • Quest Diagnostics (NYSE:DGX) upgraded to Overweight with a $120 (13% upside) at Morgan Stanley.
  • Novartis (NYSE:NVS) downgraded to Hold at HSBC Securities.

Recommended For You

About UBX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
UBX--
Unity Biotechnology, Inc.